SYT5 Human, or Synaptotagmin 5, is a recombinant protein encoded by the SYT5 gene, belonging to the synaptotagmin family of calcium-sensing membrane proteins. These proteins regulate calcium-dependent processes such as vesicle fusion, neurotransmitter release, and intracellular trafficking . SYT5 is notable for its role in modulating exocytosis in both neuronal and non-neuronal cells, including endothelial and endocrine systems .
SYT5 acts as a calcium sensor in diverse cellular processes:
Endothelial Cells: Regulates Ca²⁺-dependent exocytosis of Weibel-Palade bodies (WPBs), secretory granules storing von Willebrand factor (VWF) and inflammatory mediators .
Neuronal/Endocrine Cells: Modulates synaptic vesicle release and hormone secretion .
Affinity: SYT5 exhibits lower Ca²⁺-binding affinity compared to SYT7, making it suited for high-threshold exocytosis .
Mutation Impact: Asp197Ser mutation in the C2A domain abolishes Ca²⁺ sensing, mimicking SYT5 depletion .
Formulation: Supplied in 20 mM Tris-HCl (pH 8.0), 40% glycerol, 0.2 M NaCl, and 2 mM DTT .
Storage: Stable at 4°C for 2–4 weeks or -20°C long-term with carrier protein (e.g., 0.1% HSA) .
Pathways:
Disease Links:
Synaptotagmin 5 (SYT5) is a membrane protein that may play a crucial role in Ca²⁺-dependent exocytosis of secretory vesicles through calcium and phospholipid binding to its C2 domain. SYT5 functions as a calcium sensor in vesicular trafficking and exocytosis processes . In neuronal systems, it specifically regulates calcium-dependent secretion of neurotransmitters, as demonstrated in studies showing its regulation of norepinephrine secretion in PC12 cells .
SYT5 is also required for export from the endocytic recycling compartment to the cell surface, indicating its broader role in membrane trafficking beyond just neurotransmitter release . This protein associates with other proteins involved in vesicle docking and membrane fusion, suggesting a coordinated role in synaptic function .
The human SYT5 gene encodes a 386-amino-acid protein and is located on chromosome 19q13.4 . The gene structure features an open reading frame interrupted by seven introns that can be alternatively spliced, providing potential for expression diversity .
Interestingly, SYT5 is positioned in close proximity to another synaptotagmin family member, SYT3, on the same chromosomal region . This represents the first documented instance of linked synaptotagmin genes, which has significant implications for potential co-regulation or evolutionary development of these related proteins .
Enzyme-Linked Immunosorbent Assay (ELISA) is a highly effective method for detecting and quantifying SYT5 in various biological samples. Commercially available GENLISA Human Synaptotagmin 5 ELISA kits utilize:
Highly specific monoclonal antibody pairs for detection and coating
Proprietary stabilizers and blockers for optimal noise:signal ratio
Indirect sandwich assay with double antibodies to ensure high sensitivity and specificity
These kits are validated for use with:
For tissue-specific expression analysis, researchers should consider:
Immunohistochemistry using validated anti-SYT5 antibodies
RT-PCR for mRNA expression analysis
Western blotting for protein expression analysis in tissue lysates
When selecting a detection method, researchers should consider the specific biological context and required sensitivity levels of their experiment.
SYT5 forms functional interactions with core components of the SNARE (Soluble NSF Attachment Receptor) complex that mediates vesicle fusion with the plasma membrane. Key interaction partners include:
These interactions form the molecular basis for SYT5's function in calcium-dependent exocytosis. The SNARE complex components (STX1A and SNAP25) are typically localized on the plasma membrane, while VAMP2 resides in synaptic vesicles. When these proteins interact with SYT5, they bring membranes into close proximity, facilitating vesicle fusion .
SYT5 functions as a calcium sensor that regulates secretory vesicle exocytosis in response to calcium influx. Its mechanism of action involves:
Calcium Binding: SYT5 contains C2 domains that bind calcium ions, triggering conformational changes in the protein structure .
Membrane Interaction: Upon calcium binding, SYT5 interacts with phospholipids in the target membrane, facilitating closer approach of vesicle and plasma membranes .
SNARE Complex Modulation: SYT5 modulates the SNARE complex assembly or function, potentially by removing inhibitory factors or stabilizing intermediate states of the fusion machinery .
Fusion Pore Formation: Through its interactions with both membranes and proteins, SYT5 facilitates the formation of fusion pores that allow vesicle contents to be released .
An experimental system demonstrating this function is PC12 cells, where SYT5 has been shown to specifically regulate the calcium-dependent secretion of norepinephrine .
Human SYT5 shows significant evolutionary conservation, particularly with rodent orthologs. The human SYT5 protein shares 91% sequence identity with rat Syt V, indicating strong functional conservation across mammalian species .
The mouse Syt5 gene (MGI:1926368) is extensively studied and shows expression patterns across multiple tissue systems including the nervous system, which correlates with human expression patterns . Mouse models therefore represent valuable experimental systems for studying SYT5 function.
When researchers encounter contradictory findings regarding SYT5 function or expression, several methodological approaches can help resolve these discrepancies:
The human SYT5 gene contains seven introns that can be alternatively spliced . Different splice variants may have distinct functions or expression patterns. Researchers should:
Use primers or antibodies that can distinguish between splice variants
Explicitly state which variant is being studied
Consider if contradictory findings result from studying different variants
SYT5 may have different functions in different cell types. Resolving contradictions may require:
Single-cell RNA sequencing to identify cell-type specific expression patterns
Conditional knockout models that target specific cell populations
Co-expression analysis with cell-type specific markers
Use standardized detection methods such as validated ELISA kits
Implement rigorous controls including positive and negative controls
Consider differences in sample preparation that might affect protein detection
The human SYT5 gene contains seven introns that can undergo alternative splicing , potentially generating multiple protein isoforms with distinct functional properties. To study this:
Use RNA-Seq data to identify all expressed splice variants in tissue samples of interest
Perform RT-PCR with primers spanning potential splice junctions
Validate variant-specific primers for quantitative PCR
Express individual splice variants in cell models lacking endogenous SYT5
Compare calcium-binding properties of different isoforms using purified recombinant proteins
Assess subcellular localization patterns of different variants using isoform-specific antibodies or tagged constructs
Determine if splice variant expression changes under different physiological conditions
Investigate tissue-specific or developmental regulation of splicing
Correlate splice variant expression with functional outcomes in relevant model systems
PC12 cells: Already validated for studying SYT5's role in norepinephrine secretion
Neuronal cell lines: Useful for studying basic mechanisms of SYT5 function
Primary neuronal cultures: More physiologically relevant for neuron-specific functions
Given the high sequence identity (91%) between human and rat SYT5 , rodent models offer valuable insights:
Knockout mice: For studying loss-of-function phenotypes
Knockin models: For studying specific mutations or human variants
Conditional models: For temporal and spatial control of SYT5 expression
iPSC-derived neurons: For studying SYT5 in a human genetic background
Brain organoids: For studying SYT5 in a developmentally relevant context
Post-mortem tissue analysis: For correlating SYT5 expression with human pathology
Each model system offers distinct advantages, and the choice should be guided by the specific research question being addressed.
When using ELISA kits for SYT5 detection in different biological samples, researchers should consider these optimization strategies:
Serum samples: Minimize freeze-thaw cycles; consider dilution to reduce matrix effects
Cell culture supernatant: Account for media components that might interfere with detection
Tissue lysates: Optimize lysis buffers to ensure complete protein extraction while preserving epitope integrity
Use the standardized protocol provided with GENLISA Human Synaptotagmin 5 ELISA kits, which feature break-apart wells for ease of use
Validate lot-to-lot consistency if performing longitudinal studies
Include appropriate standards and controls in each assay run
Consider pre-concentration steps for samples with low SYT5 levels
Optimize incubation times and temperatures based on sample type
Use blocking agents appropriate for the specific sample matrix
The GENLISA ELISA kits for SYT5 use an indirect sandwich assay with double antibodies (capture and detection) to ensure high sensitivity and specificity in the estimation of Synaptotagmin 5 across various sample types .
Synaptotagmin V is a member of the synaptotagmin family, which consists of membrane-trafficking proteins characterized by their role in neurotransmitter release and hormone secretion. These proteins are integral to the process of exocytosis, where neurotransmitters are released from synaptic vesicles into the synaptic cleft .
Synaptotagmin V plays a pivotal role in the regulation of neurotransmitter release. It acts as a calcium sensor, detecting the influx of calcium ions (Ca²⁺) into presynaptic nerve terminals. This calcium binding triggers a series of events that lead to the fusion of synaptic vesicles with the presynaptic membrane, thereby releasing neurotransmitters into the synaptic cleft .
The mechanism by which synaptotagmin V facilitates neurotransmitter release involves its interaction with the SNARE complex. The SNARE complex is composed of proteins such as synaptobrevin, syntaxin, and SNAP-25, which drive the fusion of synaptic vesicles with the presynaptic membrane. Synaptotagmin V binds to these SNARE proteins in a calcium-dependent manner, promoting the fusion process .
Recombinant human synaptotagmin V is produced using Escherichia coli expression systems. This recombinant protein is typically purified to a high degree of purity (>90%) and is validated using techniques such as SDS-PAGE and mass spectrometry . Recombinant synaptotagmin V is used in various research applications to study its role in neurotransmitter release and to explore potential therapeutic applications.